A dose adjustment of TIVICAY to
50 mg twice daily is recommended in
treatment-naïve or treatmentexperienced,
INSTI-naïve patients.
Alternative combinations that do not
include metabolic inducers should be
considered where possible for INSTIexperienced
patients with certain INSTIassociated
resistance substitutions or
clinically suspected INSTI resistance.